Introduction: TAVR in Intermediate-Risk and Low-Risk With Severe Aortic Stenosis

Case Resolution: How Did We Treat this Patient?

TAVR Restenosis: Review of the Literature

Case Introduction: An 87 Year Old Woman With Recurrent Dyspnea 7 Years After TAVR

The Landscape of Alternative Access Strategies for TAVR (Apical, Direct Aorta, Subclavian, Carotid, and Caval)

Complications 2. How to Prevent and Treat Transfemoral Access Site Complications

Strategies to Reduce the Frequency of New Pacemakers After TAVR: Imaging, Procedural, and Device-Related Factors

Von Willebrand Factor Multimers During TAVR: Implications for Treatment of Para-Valvular Regurgitation

Complications 1. Para-Valvular Regurgitation: Should Mild Para-Valvular Regurgitation After TAVR Be Treated?

Controversy 5. Adjunctive Pharmacotherapy for TAVR: “Real World” Usage Patterns of Antiplatelet and Antithrombotic Agents